Anti-interferon-gamma polyclonal antibody - Advanced Biotherapy

Drug Profile

Anti-interferon-gamma polyclonal antibody - Advanced Biotherapy

Alternative Names: A-IFN-gamma; anti-IFN-γ; Anti-IFN-γ polyclonal antibody - Advanced Biotherapy

Latest Information Update: 02 Jun 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Advanced Biotherapy
  • Class Polyclonal antibodies
  • Mechanism of Action Interferon gamma inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Keratoplasty rejection

Highest Development Phases

  • Discontinued Alopecia; Epidermolysis bullosa; Herpes simplex virus infections; Keratoplasty rejection; Multiple sclerosis; Pemphigus vulgaris; Psoriasis; Rheumatoid arthritis; Systemic lupus erythematosus; Type 1 diabetes mellitus; Uveitis; Vitiligo

Most Recent Events

  • 14 Jul 2005 Data presented at the Annual European Congress of Rheumatology (EULAR-2005) have been added to the adverse events and Rheumatic Disease therapeutic trials sections
  • 21 Jan 2005 Data from a media release have been added to the Viral infections therapeutic trials section
  • 28 Oct 2004 Data from a media release have been added to the Viral Infections therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top